CL vs MEDP · P/E 34, rev $10.69B vs P/E 25, rev $707.3M
Colgate-Palmolive Company (CL) versus Medpace Holdings Inc (MEDP) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
CL currently screens at market cap $70.88B and trailing P/E 34.3. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Not investment advice. Open the CL and MEDP stock pages for the full models.
Not investment advice.